Search

Your search keyword '"Maeda, Mayumi"' showing total 132 results
Start Over Author "Maeda, Mayumi"
132 results on '"Maeda, Mayumi"'

1. Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation

Author

Matar, Abraham J., Oppat, Kailey M., Bennett, Frances J., Warren, Emilie A. K., Wehrle, Chase J., Li, Zhihao, Rajendran, Luckshi, Rokop, Zachary P., Kubal, Chandrashekhar, Biesterveld, Ben E., Foley, David P., Maeda, Mayumi, Nguyen, Mindie H., Elinoff, Beth, Humar, Abhinav, Moris, Dimitrios, Sudan, Debra, Klein, John, Emamaullee, Juliet, Agopian, Vatche, Vagefi, Parsia A., Dualeh, Shukri H. A., Sonnenday, Christopher J., Sapisochin, Gonzalo, Aucejo, Federico N., and Maithel, Shishir K.

Published
2024
Full Text
View/download PDF

2. ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation

Author

Matar, Abraham J., Oppat, Kailey M., Bennett, Frances J., Warren, Emilie A. K., Wehrle, Chase J., Li, Zhihao, Rajendran, Luckshi, Rokop, Zachary P., Kubal, Chandrashekhar, Biesterveld, Ben E., Foley, David P., Maeda, Mayumi, Nguyen, Mindie H., Elinoff, Beth, Humar, Abhinav, Moris, Dimitrios, Sudan, Debra, Klein, John, Emamaullee, Juliet, Agopian, Vatche, Vagefi, Parsia A., Dualeh, Shukri H. A., Sonnenday, Christopher J., Sapisochin, Gonzalo, Aucejo, Federico N., and Maithel, Shishir K.

Published
2024
Full Text
View/download PDF

3. Flavor assessment of a lactic fermented vinegar described in Japanese books from the Edo period (1603–1867)

Author

Naoyuki Yanagihara, Maeda Mayumi, Jun Yoshikawa, Sayuri Akuzawa, Akira Fujii, Masanobu Nagano, Yukimichi Koizumi, and Kenji Maehashi

Subjects
Edo period, Japanese cuisine, Kurozu, Lactic fermentation, Rice vinegar, Sourness, Science (General), Q1-390, Social sciences (General), H1-99
Abstract

Aims: Rice vinegar is a traditional fermented seasoning in Japan, and its production remained unchanged for over 800 years until the Edo period. However, based on the available information regarding rice vinegar production methods from this period and the results of reproduction experiments, we speculated that unlike the modern-day acetic fermented vinegar, rice vinegar produced during the Edo period was lactic fermented. Main methods: To verify this assumption, we analyzed the flavor components of Honcho, a lactic fermented product prepared using a method described in books, including ''Honchoshokkan'' from the Edo period, by capillary electrophoresis/time-of-flight mass spectrometry, high-performance liquid chromatography, gas chromatography mass spectrometry, and taste sensor analysis. Sensory evaluation was also conducted to assess validation as a seasoning. Results: Honcho contains 2 % lactic acid, which gives it its acidity, and small amounts of other nonvolatile acids, but significantly lower levels of acetic acid (0.188 ± 0.015 g/100 mL, p

Published
2024
Full Text
View/download PDF

4. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study

Author

Wong, Yu Jun, Tran, Sally, Huang, Chung-Feng, Hsu, Yao-Chun, Preda, Carmen, Toyoda, Hidenori, Liu, Joanne, Jun, Dae Won, Landis, Charles, Huang, Daniel Q., Gila, Andrei, Negoita, Livia, Yasuda, Satoshi, Tseng, Cheng-Hao, Tsai, Pei-Chien, Uojima, Haruki, Nozaki, Akito, Chuma, Makoto, Atsukawa, Masanori, Ishigami, Masatoshi, Itokawa, Norio, Iio, Etsuko, Lam, Carla Pui-Mei, Watanabe, Tsunamasa, Asai, Akira, Yokohama, Keisuke, Abe, Hiroshi, Enomoto, Masaru, Kawada, Norifumi, Tamori, Akihiro, Lee, Dong Hyun, Jun, Mi Jung, Do, Son, Vo, Dang K. H., Liu, Li, Li, Junyi, Ji, Fanpu, Wang, Wenjun, Li, Yu, Wang, Xiaozhong, Guo, Fen, Xu, Qiang, Jing, Liang, Ye, Qing, Pan, Hongying, Zhang, JiaJie, Wen, Xie, Wang, Qi, Ren, Hong, Cai, Dachuan, Shang, Jia, Liu, Junping, Lu, Chengzheng, Zang, Wenqian, Li, Jia, Niu, Junqi, Zhang, Mingyuan, Wu, Chao, Huang, Rui, Maeda, Mayumi, Nakanishi, Akiko, Yeh, Ming-Lun, Chuang, Wan-Long, Huang, Jee-Fu, Dai, ChiaYen, Ishikawa, Toru, Takaguchi, Koichi, Senoh, Tomonori, Trinh, Huy N., Takahashi, Hirokazu, Eguchi, Yuichiro, Quek, Sabrina Xin Zi, Haga, Hiroaki, Ogawa, Eiichi, Wong, Grace, Buti, Maria, Fukunishi, Shinya, Ueno, Yoshiyuki, Yuen, Man-Fung, Tanaka, Yasuhito, Lim, Seng Gee, Cheung, Ramsey, Yu, Ming-Lung, and Nguyen, Mindie H.

Published
2023
Full Text
View/download PDF

5. Sex and ethnic disparities in hepatitis B evaluation and treatment across the world

Author

Kudaravalli, Sahith, Huang, Daniel Q., Yeh, Ming-Lun, Trinh, Lindsey, Tsai, P.C., Hsu, Yao-Chun, Kam, Leslie Y., Nguyen, Vy H., Ogawa, Eiichi, Lee, Dong Hyun, Ito, Takanori, Watanabe, Tsunamasa, Enomoto, Masaru, Preda, Carmen Monica, Ko, Michael K.L., Wan-Hin Hui, Rex, Atsukawa, Masanori, Suzuki, Takanori, Marciano, Sebastian, Barreira, Ana, Do, Son, Uojima, Haruki, Takahashi, Hirokazu, Quek, Sabrina X.Z., Toe Wai Khine, Htet Htet, Ishigami, Masatoshi, Itokawa, Norio, Go, Min Seok, Kozuka, Ritsuzo, Marin, Raluca Ioana, Sandra, Irina, Li, Jiayi, Zhang, Jian Q., Wong, Christopher, Yoshimaru, Yoko, Vo, Dang K.H., Tseng, Cheng-Hao, Lee, Chul-jin, Inoue, Kaori, Maeda, Mayumi, Hoang, Joseph K., Chau, Angela, Chuang, Wan-Long, Dai, Chia-Yen, Huang, Jee-Fu, Huang, Chung-Feng, Buti, Maria, Tanaka, Yasuhito, Gadano, Adrian Carlos, Yuen, Man-Fung, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N., Toyoda, Hidenori, Yu, Ming-Lung, and Nguyen, Mindie H.

Published
2024
Full Text
View/download PDF

7. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study

Author

Chau, Angela, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Daniel Q., Kim, Sung Eun, Trinh, Huy, Yoon, Eileen L., Oh, Hyunwoo, Jeong, Jae Yoon, Ahn, Sang Bong, An, Jihyun, Tseng, Cheng-Hao, Hsu, Yao-Chun, Jeong, Soung Won, Cho, Yong Kyun, Shim, Jae-Jun, Kim, Hyoung Su, Ito, Takanori, Marciano, Sebastián, Kawashima, Keigo, Suzuki, Takanori, Watanabe, Tsunamasa, Nozaki, Akito, Ishikawa, Toru, Inoue, Kaori, Eguchi, Yuichiro, Uojima, Haruki, Abe, Hiroshi, Takahashi, Hirokazu, Chuma, Makoto, Ishigami, Masatoshi, Hoang, Joseph K., Maeda, Mayumi, Huang, Chung-Feng, Gadano, Adrian, Dai, Chia-Yen, Huang, Jee-Fu, Tanaka, Yasuhito, Chuang, Wan-Long, Lim, Seng Gee, Cheung, Ramsey, Yu, Ming-Lung, Jun, Dae-Won, and Nguyen, Mindie H.

Published
2024
Full Text
View/download PDF

11. d-Arabitol production by a high arabitol-producing yeast, Zygosaccharomycessp. Gz-5 isolated from miso

Author

Iwata, Kan, Kanokozawa, Rikuo, Iwata, Aoi, Maeda, Mayumi, Maehashi, Kenji, and Yoshikawa, Jun

Abstract

d-Arabitol, an alternative sweetener to sugar, has low calorie content, high sweetness, low glycemic index, and insulin resistance-improving ability. In this study, d-arabitol-producing yeast strains were isolated from various commercial types of miso, and strain Gz-5 was selected among these strains. Phylogenetic tree analysis of the internal transcribed spacer sequence revealed that strain Gz-5 was distinct from Zygosaccharomyces rouxii, a major fermenting yeast of miso. The strain, identified as Zygosaccharomycessp. Gz-5, grew better than other Z. rouxiiin 150 g/L NaCl and produced 114 g/L d-arabitol from 295 g/L glucose in a batch culture for 8 days (0.386 g/g-consumed glucose). In a fed-batch culture, the yeast produced 133 g/L d-arabitol for 14 days, and the total d-arabitol amount increased by 1.75-fold. These results indicated that Zygosaccharomycessp. Gz-5, a non-genetically modified strain, has excellent potential for the industrial production of d-arabitol.Graphical AbstractZygosaccharomycessp. Gz-5 was isolated as d-arabitol-producing yeast, and its production was increased in fed-batch culture.

Published
2024
Full Text
View/download PDF

12. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

Author

Ito, Takanori, Ishigami, Masatoshi, Zou, Biyao, Tanaka, Taku, Takahashi, Hirokazu, Kurosaki, Masayuki, Maeda, Mayumi, Thin, Khin Naing, Tanaka, Kenichi, Takahashi, Yuka, Itoh, Yoshito, Oniki, Kentaro, Seko, Yuya, Saruwatari, Junji, Kawanaka, Miwa, Atsukawa, Masanori, Hyogo, Hideyuki, Ono, Masafumi, Ogawa, Eiichi, Barnett, Scott D., Stave, Christopher D., Cheung, Ramsey C., Fujishiro, Mitsuhiro, Eguchi, Yuichiro, Toyoda, Hidenori, and Nguyen, Mindie H.

Published
2021
Full Text
View/download PDF

14. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma

Author

Huang, Daniel Q., primary, Hoang, Joseph K., additional, Kamal, Rubayet, additional, Tsai, Pei-Chien, additional, Toyoda, Hidenori, additional, Yeh, Ming-Lun, additional, Yasuda, Satoshi, additional, Leong, Jennifer, additional, Maeda, Mayumi, additional, Huang, Chung-Feng, additional, Won Jun, Dae, additional, Ishigami, Masatoshi, additional, Tanaka, Yasuhito, additional, Uojima, Haruki, additional, Ogawa, Eiichi, additional, Abe, Hiroshi, additional, Hsu, Yao-Chun, additional, Tseng, Cheng-Hao, additional, Alsudaney, Manaf, additional, Yang, Ju Dong, additional, Yoshimaru, Yoko, additional, Suzuki, Takanori, additional, Liu, Joanne K., additional, Landis, Charles, additional, Dai, Chia-Yen, additional, Huang, Jee-Fu, additional, Chuang, Wan-Long, additional, Schwartz, Myron, additional, Dan, Yock Young, additional, Esquivel, Carlos, additional, Bonham, Andrew, additional, Yu, Ming-Lung, additional, and Nguyen, Mindie H., additional

Published
2024
Full Text
View/download PDF

15. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response

Author

Park, Jung Eun, primary, Nguyen, Vy H., additional, Tsai, Pei‐Chien, additional, Toyoda, Hidenori, additional, Leong, Jennifer, additional, Guy, Jennifer E., additional, Yeh, Ming‐Lun, additional, Huang, Chung‐Feng, additional, Yasuda, Satoshi, additional, Abe, Hiroshi, additional, Hsu, Yao‐Chun, additional, Tseng, Cheng‐Hao, additional, Liu, Joanne, additional, Chen, Yao‐Li, additional, Lin, Ping‐Yi, additional, Jun, Dae Won, additional, Yoshimaru, Yoko, additional, Ogawa, Eiichi, additional, Ishigami, Masatoshi, additional, Enomoto, Masaru, additional, Tamori, Akihiro, additional, Uojima, Haruki, additional, Wang, Xiao Zhong, additional, Xu, Qiang, additional, Takahashi, Hirokazu, additional, Eguchi, Yuichiro, additional, Inoue, Kaori, additional, Huang, Daniel Q., additional, Zhao, Wen Jing, additional, Chuang, Wan‐Long, additional, Dai, Chia‐Yen, additional, Huang, Jee‐Fu, additional, Barnett, Scott, additional, Maeda, Mayumi, additional, Cheung, Ramsey, additional, Landis, Charles, additional, Tanaka, Yasuhito, additional, Roberts, Lewis R., additional, Schwartz, Myron E., additional, Kumada, Takashi, additional, Yu, Ming‐Lung, additional, and Nguyen, Mindie H., additional

Published
2024
Full Text
View/download PDF

18. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study

Author

Nguyen, Vy H., primary, Le, Isaac, additional, Ha, Audrey, additional, Le, Richard Hieu, additional, Rouillard, Nicholas Ajit, additional, Fong, Ashley, additional, Gudapati, Surya, additional, Park, Jung Eun, additional, Maeda, Mayumi, additional, Barnett, Scott, additional, Cheung, Ramsey, additional, and Nguyen, Mindie H., additional

Published
2023
Full Text
View/download PDF

20. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Author

Huang, Daniel Q., primary, Tran, Andrew, additional, Yeh, Ming-Lun, additional, Yasuda, Satoshi, additional, Tsai, Pei-Chien, additional, Huang, Chung-Feng, additional, Dai, Chia Yen, additional, Ogawa, Eiichi, additional, Ishigami, Masatoshi, additional, Ito, Takanori, additional, Kozuka, Ritsuzo, additional, Enomoto, Masaru, additional, Suzuki, Takanori, additional, Yoshimaru, Yoko, additional, Preda, Carmen M., additional, Marin, Raluca I., additional, Sandra, Irina, additional, Tran, Sally, additional, Quek, Sabrina X.Z., additional, Khine, Htet Htet Toe Wai, additional, Itokawa, Norio, additional, Atsukawa, Masanori, additional, Uojima, Haruki, additional, Watanabe, Tsunamasa, additional, Takahashi, Hirokazu, additional, Inoue, Kaori, additional, Maeda, Mayumi, additional, Hoang, Joseph K., additional, Trinh, Lindsey, additional, Barnett, Scott, additional, Cheung, Ramsey, additional, Lim, Seng Gee, additional, Trinh, Huy N., additional, Chuang, Wan-Long, additional, Tanaka, Yasuhito, additional, Toyoda, Hidenori, additional, Yu, Ming-Lung, additional, and Nguyen, Mindie H., additional

Published
2023
Full Text
View/download PDF

21. Su1551 CLINICAL PRESENTATION AND SURVIVAL IN MALE COMPARED TO FEMALE PATIENTS WITH CIRRHOSIS: A LONG-TERM COHORT STUDY OF 13,228 REAL-WORLD PATIENTS

Author

Fong, Ashley, primary, Tran, Sally, additional, Ha, Audrey, additional, Nguyen, Vy H., additional, Park, Jung Eun, additional, Maeda, Mayumi, additional, Hand, Catherine, additional, Lee, KeeSeok, additional, Nascimento, Melissa, additional, Jung, Janghan, additional, Zhao, Changqing, additional, Jin, Mingjuan, additional, Gao, Kai, additional, Cheung, Ramsey, additional, and Nguyen, Mindie H., additional

Published
2023
Full Text
View/download PDF

22. Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study.

Author

Ogawa, Eiichi, Jun, Dae Won, Toyoda, Hidenori, Hsu, Yao‐Chun, Yoon, Eileen L., Ahn, Sang Bong, Yeh, Ming‐Lun, Do, Son, Trinh, Huy N., Takahashi, Hirokazu, Enomoto, Masaru, Kawada, Norifumi, Yasuda, Satoshi, Tseng, Cheng‐Hao, Kawashima, Keigo, Lee, Han Ah, Inoue, Kaori, Haga, Hiroaki, Do, Ai‐Thien, and Maeda, Mayumi

Subjects
CHRONIC hepatitis B, BONE density, SPINE, TENOFOVIR, ALANINE aminotransferase, GLOMERULAR filtration rate
Abstract

Summary: Background: Data on patients switched to tenofovir alafenamide (TAF) from nucleos(t)ide analogues (NUCs) other than tenofovir disoproxil fumarate are limited. Aims: To assess the treatment and renal/bone safety outcomes following the switch to TAF. Methods: We prospectively enrolled adult patients with chronic hepatitis B (CHB) who switched from any NUC to TAF at 14 centres in Japan, Korea, Taiwan and the U.S. Study outcomes were viral suppression (VR; HBV DNA < 20 IU/mL), biochemical response (BR; alanine aminotransferase normalisation), and changes in estimated glomerular filtration rate (eGFR) and T‐scores (L‐spine) by bone absorptiometry by 24 months after switch to TAF. Results: We enrolled 270 eligible patients. Mean age was 58.1; 58.2% were male; 12.2% had cirrhosis and 73.3% previously received entecavir monotherapy. VR rate increased significantly from 95.2% to 98.8% by 24 months after the switch to TAF (p = 0.014). Between the switch and 24 months later, the mean spine T‐score improved significantly from −1.43 ± 1.36 to −1.17 ± 1.38 (p < 0.0001), while there was no significant change in mean eGFR (88.4 ± 16.9–89.5 ± 16.3 mL/min/1.73 m2, p = 0.13). On multivariable analysis adjusted for age, sex, baseline spine T‐score and prior TDF or adefovir dipivoxil use, male sex was significantly associated with lower risk of worsening spine T‐score (odds ratio: 0.29, p = 0.020), while age was significantly associated with a higher risk of worsening chronic kidney disease stage (OR: 1.07, p = 0.019). Conclusions: At 24 months after the switch to TAF, VR rates and spine bone density improved significantly while renal function remained stable. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients

Author

Liu, Joanne K., primary, Vutien, Philip, additional, Huang, Daniel Q., additional, Ishigami, Masatoshi, additional, Landis, Charles S., additional, Nguyen, Mindie H., additional, Daniel, Peter Chen-Yang Nikhil, additional, Ito, Takanori, additional, Dang, Hansen, additional, Maeda, Mayumi, additional, and Leong, Jennifer, additional

Published
2023
Full Text
View/download PDF

25. Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study

Author

Ogawa, Eiichi, primary, Jun, Dae Won, additional, Toyoda, Hidenori, additional, Hsu, Yao-Chun, additional, Yoon, Eileen, additional, Ahn, Sang Bong, additional, Do, Son, additional, Trinh, Huy, additional, Takahashi, Hirokazu, additional, Enomoto, Masaru, additional, Yasuda, Satoshi, additional, Tseng, Cheng-Hao, additional, Yeh, Ming-Lun, additional, Kawashima, Keigo, additional, Lee, Han Ah, additional, Inoue, Kaori, additional, Haga, Hiroaki, additional, Do, Ai-Thien, additional, Maeda, Mayumi, additional, Hoang, Joseph, additional, Cheung, Ramsey C., additional, Ueno, Yoshiyuki, additional, Eguchi, Yuichiro, additional, Furusyo, Norihiro, additional, Yu, Ming-Lung, additional, Tanaka, Yasuhito, additional, and Nguyen, Mindie, additional

Published
2022
Full Text
View/download PDF

26. 328: REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY

Author

Wong, Yu Jun, primary, Tran, Sally, additional, Huang, Chung-Feng, additional, Hsu, Yao-Chun, additional, Preda, Carmen M., additional, Toyoda, Hidenori, additional, Liu, Joanne, additional, Jun, Dae Won, additional, Landis, Charles, additional, Huang, Daniel, additional, Gila, Andrei B., additional, Negoita, Livia, additional, Yasuda, Satoshi, additional, Tseng, Cheng-Hao, additional, Tsai, Pei-Chien, additional, Uojima, Haruki, additional, Nozaki, Akito, additional, Chuma, Makoto, additional, Atsukawa, Masanori, additional, itokawa, norio, additional, Iio, Etsuko, additional, Lam, Carla, additional, Watanabe, Tsunemasa, additional, Keisuke, Yokohama, additional, Abe, Hiroshi, additional, Enomoto, Masaru, additional, Tamori, Akihiro, additional, Lee, Dong-Hyun, additional, Jun, Mijung, additional, Maeda, Mayumi, additional, Nakanishi, Akiko, additional, Yeh, Ming-Lun, additional, Chuang, Wan-Long, additional, Huang, Jee-Fu, additional, Dai, Chia-Yen, additional, Ishikawa, Toru, additional, Takaguchi, Koichi, additional, Senoo, Tomonori, additional, Trinh, Huy N., additional, Takahashi, Hirokazu, additional, Eguchi, Yuichiro, additional, Quek, Sabrina X., additional, Haga, Hiroaki, additional, Ogawa, Eiichi, additional, Wong, Grace L., additional, Buti, Maria, additional, Fukunishi, Shinya, additional, Ueno, Yoshiyuki, additional, Yuen, Man-Fung, additional, Tanaka, Yasuhito, additional, Lim, Seng Gee, additional, Cheung, Ramsey, additional, Yu, Ming-Lung, additional, and Nguyen, Mindie H., additional

Published
2022
Full Text
View/download PDF

27. Sa1396: ANTIVIRAL THERAPY IMPROVES SURVIVAL IN VIRAL-ASSOCIATED HEPATOCELLULAR CARCINOMA AFTER LIVER RESECTION BUT IS SEVERELY UNDERUTILIZED

Author

Huang, Daniel, primary, Kamal, Rubayet, additional, Tsai, Pei-Chien, additional, Toyoda, Hidenori, additional, Yeh, Ming-Lun, additional, Yasuda, Satoshi, additional, Leong, Jennifer, additional, Hoang, Joseph, additional, Maeda, Mayumi, additional, Huang, Chung-Feng, additional, Jun, Dae Won, additional, Bonham, Andrew, additional, Ogawa, Eiichi, additional, Uojima, Haruki, additional, Abe, Hiroshi, additional, Hsu, Yao-Chun, additional, Tseng, Cheng-Hao, additional, Liu, Joanne, additional, Landis, Charles, additional, Dai, Chia-Yen, additional, Huang, Jee-Fu, additional, Chuang, Wan-Long, additional, Schwartz, Myron, additional, Dan, Yock Young, additional, Esquivel, Carlos O., additional, Yu, Ming-Lung, additional, Nguyen, Mindie H., additional, Suzuki, Takanori, additional, and Tanaka, Yasuhito, additional

Published
2022
Full Text
View/download PDF

28. Su1339: SEX DIFFERENCES IN VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A MULTICENTER LONGITUDINAL STUDY

Author

Chau, Angela, primary, Huang, Daniel, additional, Yeh, Ming-Lun, additional, Tsai, Pei-Chien, additional, Kim, Sung Eun, additional, Yoon, Eileen, additional, Oh, Hyunwoo, additional, Jeong, Jae Yoon, additional, Ahn, Sang Bong, additional, An, Jihyun, additional, Jeong, Soung Won, additional, Cho, Yong Kyun, additional, Kim, Hyoung Su, additional, Marciano, Sebastian, additional, Huang, Chung-Feng, additional, Trinh, Huy N., additional, Hoang, Joseph, additional, Maeda, Mayumi, additional, Dai, Chia-Yen, additional, Huang, Jee-Fu, additional, Gadano, Adrian, additional, Chuang, Wan-Long, additional, Jun, Dae Won, additional, Yu, Ming-Lung, additional, and Nguyen, Mindie H., additional

Published
2022
Full Text
View/download PDF

30. Sa1606 SEVERE UNDERUTILIZATION OF PALLIATIVE/HOSPICE CARE AND DISCUSSION AMONG PATIENTS WITH CIRRHOSIS INCLUDING THOSE WITH DECOMPENSATION AND HCC: FINDINGS FROM A SINGLE-CENTER REAL-WORLD STUDY OF 15.876 PATIENTS

Author

Fung, Annie, Liu, Joanne K., Fong, Ashley, Gudapati, Surya T., Nguyen, Vy H., Park, Jung Eun, Le, Isaac, Lee, KeeSeok, Chau, Angela, Tran, Sally, Kam, Leslie Y., Zhang, Xinrong, Maeda, Mayumi, Cheung, Ramsey, Zhao, Changqing, Jin, Mingjuan, and Nguyen, Mindie H.

Published
2024
Full Text
View/download PDF

31. Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice

Author

Toyoda, Hidenori, primary, Leong, Jennifer, additional, Landis, Charles, additional, Atsukawa, Masanori, additional, Watanabe, Tsunamasa, additional, Huang, Daniel Q., additional, Liu, Joanne, additional, Quek, Sabrina Xin Zi, additional, Ishikawa, Toru, additional, Arai, Taeang, additional, Yokohama, Keisuke, additional, Chuma, Makoto, additional, Takaguchi, Koichi, additional, Uojima, Haruki, additional, Senoo, Tomonori, additional, Dang, Hansen, additional, Maeda, Mayumi, additional, Hoang, Joseph, additional, Le, Richard H., additional, Yasuda, Satoshi, additional, Thin, Khin N., additional, Tran, Sally, additional, Chien, Nicholas, additional, Henry, Linda, additional, Asai, Akira, additional, Fukunishi, Shinya, additional, Cheung, Ramsey, additional, Lim, Seng Gee, additional, Trinh, Huy N., additional, and Nguyen, Mindie H., additional

Published
2021
Full Text
View/download PDF

32. Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma

Author

Huang, Daniel Q., primary, Hoang, Joseph K., additional, Leong, Jennifer, additional, Riveiro‐Barciela, Mar, additional, Maeda, Mayumi, additional, Yang, Ju Dong, additional, Accarino, Elena Vargas, additional, Thin, Khin, additional, Trinh, Lindsey, additional, Cheung, Ramsey C., additional, Roberts, Lewis R., additional, Buti, Maria, additional, Schwartz, Myron, additional, and Nguyen, Mindie H., additional

Published
2021
Full Text
View/download PDF

34. Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir

Author

Nguyen, Mindie H., primary, Atsukawa, Masanori, additional, Ishikawa, Toru, additional, Yasuda, Satoshi, additional, Yokohama, Keisuke, additional, Trinh, Huy N., additional, Arai, Taeang, additional, Fukunishi, Shinya, additional, Ogawa, Eiichi, additional, Hsu, Yao-Chun, additional, Maeda, Mayumi, additional, Dang, Hansen, additional, Tseng, Cheng-Hao, additional, Takahashi, Hirokazu, additional, Jun, Dae Won, additional, Watanabe, Tsunamasa, additional, Chuma, Makoto, additional, Nozaki, Akito, additional, Kawada, Norifumi, additional, Cheung, Ramsey, additional, Enomoto, Masaru, additional, Takaguchi, Koichi, additional, and Toyoda, Hidenori, additional

Published
2021
Full Text
View/download PDF

35. Mo1527 VIROLOGIC (VR), BIOCHEMICAL (BR), COMPLETE RESPONSE (CR) AND HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE AMONG MALE AND FEMALE PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS(T)IDES (NUC): A REAL-B STUDY

Author

Chau, Angela, Yeh, Ming-Lun, Tsai, Pei-Chien, Huang, Daniel, Kim, Sung Eun, Trinh, Huy N., Yoon, Eileen, Oh, Hyunwoo, Jeong, Jae Yoon, Ahn, Sang Bong, An, Jihyun, Tseng, Cheng-Hao, Hsu, Yao-Chun, Jeong, Soung Won, Cho, Yong Kyun, Shim, Jae-Jun, Kim, Hyoung-Su, Ito, Takanori, Marciano, Sebastian, Kawashima, Keigo, Watanabe, Tsunemasa, Nozaki, Akito, Ishikawa, Toru, Inoue, Kaori, Eguchi, Yuichiro, Uojima, Haruki, Abe, Hiroshi, Takahashi, Hirokazu, Chuma, Makoto, Ishigami, Masatoshi, Hoang, Joseph, Maeda, Mayumi, Huang, Chung-Feng, Gadano, Adrian, Dai, Chia-Yen, Huang, Jee-Fu, Tanaka, Yasuhito, Chuang, Wan-Long, Lim, Seng Gee, Jun, Dae Won, Yu, Ming-Lung, and Nguyen, Mindie H.

Published
2023
Full Text
View/download PDF

38. Speciation of aluminum in rainwater using a fluoride ion-selective electrode and ion-exchange chromatography with fluorometric detection of the aluminum-lumogallion complex

Author

Hara, Hirokazu, Kobayashi, Hidemasa, Maeda, Mayumi, Ueno, Ai, and Kobayashi, Yohko

Subjects
Chemistry, Analytic -- Research, Aluminum -- Research, Rain-water (Water-supply) -- Analysis, Electrodes, Ion selective -- Usage, Fluorides -- Usage, Ion exchange chromatography -- Usage, Fluorimetry -- Usage, Ions -- Identification and classification, Chemistry
Abstract

Soluble aluminum in rainwater was separated into three categories: free aluminum ([Al.sup.3+]), fluoride complexes (sum of Al[F.sub.2.sup.+] and Al[F.sup.2+]), and other forms of aluminum. The free form of the aluminum ion ([Al.sup.3+]) was directly obtained from the separation data of aluminum species according to their charge using gradient elution cation-exchange chromatography. The aluminum fluoride complexes were estimated by combining the data of the free and total fluoride determined using a fluoride ion-selective electrode, with the assumption that 2+ charged aluminum species consisted only of Al[F.sup.2+]. The rest of the aluminum species had a 1+, neutral, or negative charge and mainly consisted of organic complexes. The origin of the organically bound aluminum is discussed. The concentration range of the total dissolved fluoride and aluminum in the rainwater samples was usually in the micromolar to submicromolar range, and the ratio of [T-F]/[T-Al] was found to be between 1 and 4. The speciation of dissolved aluminum into three categories was carried out on the basis of data of 15 rainwater samples collected in the city of Otsu.

Published
2001

39. Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma

Author

Chen, Vincent L., primary, Yeh, Ming‐Lun, additional, Yang, Ju Dong, additional, Leong, Jennifer, additional, Huang, Daniel Q., additional, Toyoda, Hidenori, additional, Chen, Yao‐Li, additional, Guy, Jennifer, additional, Maeda, Mayumi, additional, Tsai, Pei‐Chien, additional, Huang, Chung‐Feng, additional, Yasuda, Satoshi, additional, Le, An K., additional, Dang, Hansen, additional, Giama, Nasra H., additional, Ali, Hamdi A., additional, Zhang, Ning, additional, Wang, Xiaozhong, additional, Jun, Dae Won, additional, Tseng, Cheng‐Hao, additional, Hsu, Yao‐Chun, additional, Huang, Jee‐Fu, additional, Dai, Chia‐Yen, additional, Chuang, Wan‐Long, additional, Zhu, Qiang, additional, Dan, Yock Young, additional, Schwartz, Myron, additional, Roberts, Lewis R., additional, Yu, Ming‐Lung, additional, and Nguyen, Mindie H., additional

Published
2020
Full Text
View/download PDF

41. High hepatitis C virus cure rates with approved interferon‐free direct‐acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b

Author

Ji, Fanpu, primary, Li, Jie, additional, Liu, Li, additional, Liang, Jing, additional, Wang, Xiaozhong, additional, Liu, Junping, additional, Cai, Dachuan, additional, Huang, Rui, additional, Zhang, Jiajie, additional, Wang, Qi, additional, Nan, Yuemin, additional, Li, Junyi, additional, Ye, Qing, additional, Zhang, Mingyuan, additional, Xu, Qiang, additional, Guo, Feng, additional, Zhao, Changqing, additional, Liu, Lingdi, additional, He, Caini, additional, Li, Yu, additional, Wang, Wenjun, additional, Kam, Leslie Y, additional, Tran, Sally, additional, Maeda, Mayumi, additional, Mizuta, Akiko, additional, Li, Zongfang, additional, Dang, Shuangsuo, additional, Ren, Wanhua, additional, Zhu, Qiang, additional, Cheung, Ramsey, additional, Niu, Junqi, additional, Xie, Wen, additional, Pan, Hongying, additional, Ren, Hong, additional, Wu, Chao, additional, Shang, Jia, additional, Wang, Fengmei, additional, and Nguyen, Mindie H, additional

Published
2020
Full Text
View/download PDF

43. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

Author

Dang, Hansen, primary, Yeo, Yee Hui, additional, Yasuda, Satoshi, additional, Huang, Chung‐Feng, additional, Iio, Etsuko, additional, Landis, Charles, additional, Jun, Dae Won, additional, Enomoto, Masaru, additional, Ogawa, Eiichi, additional, Tsai, Pei‐Chien, additional, Le, An, additional, Liu, Matthew, additional, Maeda, Mayumi, additional, Nguyen, Brian, additional, Ramrakhiani, Nathan, additional, Henry, Linda, additional, Cheung, Ramsey, additional, Tamori, Akihiro, additional, Kumada, Takashi, additional, Tanaka, Yasuhito, additional, Yu, Ming‐Lung, additional, Toyoda, Hidenori, additional, and Nguyen, Mindie H., additional

Published
2020
Full Text
View/download PDF

46. Validity of International Classification of Diseases, Tenth Revision, Codes for Cirrhosis.

Author

Ramrakhiani, Nathan S., Le, Michael H., Yeo, Yee Hui, Le, An K., Maeda, Mayumi, and Nguyen, Mindie H.

Subjects
INTERNATIONAL Statistical Classification of Diseases & Related Health Problems, NOSOLOGY, CHRONIC hepatitis B, NON-alcoholic fatty liver disease, RECEIVER operating characteristic curves, CIRRHOSIS of the liver, LIVER disease diagnosis
Abstract

Introduction: Accurate identification of patients with cirrhosis is important for research using administrative databases. We aimed to examine the accuracy of several major ICD-10 codes for cirrhosis diagnosis in a large and diverse patient cohort; there is little existing research on this topic. Methods: Using data from 3,396 patients with chronic liver disease (hepatitis B or C or nonalcoholic fatty liver disease) from 1 university and several community medical centers, we calculated sensitivity, specificity, positive predictive value (PPV), negative predictive value, and area under the receiver operating characteristic curve (AUROC) for several major ICD-10 codes for cirrhosis, which was verified by individual chart review. We performed a secondary validation in a general cohort of 1,560 randomly selected patients. Results: While each of the individual study ICD-10 codes were specific (98.08–100%), none of the codes were sufficiently sensitive (0.27–55.70%). PPVs were high in the chronic liver disease cohort (88.41–100%) but lower in the general population (55.53–66.76%). The AUROC for having at least 1 code was higher (0.79) than any code alone (0.50–0.65). Discussion/Conclusion: Individual ICD-10 codes are suboptimal for identifying patients with cirrhosis in the general patient population. We recommend conditioning ICD-10 code searches with a chronic liver disease diagnosis code and/or combining diagnostic codes to maximize performance. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

50. Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma.

Author

Chen, Vincent L., Yeh, Ming‐Lun, Yang, Ju Dong, Leong, Jennifer, Huang, Daniel Q., Toyoda, Hidenori, Chen, Yao‐Li, Guy, Jennifer, Maeda, Mayumi, Tsai, Pei‐Chien, Huang, Chung‐Feng, Yasuda, Satoshi, Le, An K., Dang, Hansen, Giama, Nasra H., Ali, Hamdi A., Zhang, Ning, Wang, Xiaozhong, Jun, Dae Won, and Tseng, Cheng‐Hao

Subjects
CIRRHOSIS of the liver, FATTY liver, HEPATOCELLULAR carcinoma
Abstract

Metabolic‐associated fatty liver disease (MAFLD) is a major cause of liver‐related complications, including hepatocellular carcinoma (HCC). While MAFLD‐related HCC is known to occur in the absence of cirrhosis, our understanding of MAFLD‐related HCC in this setting is limited. Here, we characterize MAFLD‐related HCC and the impact of cirrhosis and screening on survival. This was a multicenter, retrospective, cohort study of MAFLD‐related HCC. MAFLD was defined based on the presence of race‐adjusted overweight, diabetes, or both hypertension and dyslipidemia in the absence of excess alcohol use or other underlying cause of liver disease. The primary outcome of interest was overall survival, and the primary dependent variables were cirrhosis status and prior HCC screening. We used Kaplan‐Meier methods to estimate overall survival and Cox proportional hazards models and random forest machine learning to determine factors associated with prognosis. This study included 1,382 patients from 11 centers in the United States and East/Southeast Asia. Cirrhosis was present in 62% of patients, but under half of these patients had undergone imaging within 12 months of HCC diagnosis. Patients with cirrhosis were more likely to have early stage disease but less often received curative therapy. After adjustment, cirrhosis was not associated with prognosis, but the presence of cancer‐related symptoms at diagnosis was associated with poorer prognosis. Conclusion: Cirrhosis was not associated with overall survival in this cohort of MAFLD‐related HCC, while diagnosis in the presence of symptoms was associated with poorer prognosis. The HCC surveillance rate in patients with MAFLD‐related HCC was disappointingly low in a multicenter cohort. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results